Overview

Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study compared the pharmacokinetic and pharmacodynamic properties of an oral insulin formulation with that of a standard subcutaneous injection of regular human insulin.
Phase:
Phase 1
Details
Lead Sponsor:
Profil Institut für Stoffwechselforschung GmbH
Collaborator:
Emisphere Technologies, Inc.
Treatments:
Insulin
Insulin, Globin Zinc